You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RAS

Showing 1 - 25 of 1,693
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rhythmic Auditory Stimulation on Neural Activity During

Not yet recruiting
  • Acoustic Stimulation
  • +2 more
  • noF-noRAS
  • +5 more
  • (no location specified)
Apr 28, 2023

Parkinson Disease Trial (Rhythmic Auditory Stimulation (RAS))

Not yet recruiting
  • Parkinson Disease
  • Rhythmic Auditory Stimulation (RAS)
  • (no location specified)
Mar 9, 2023

Tislelizumab, Bevacizumab, Oxaliplatin Trial in Beijing (Tislelizumab+Bevacizumab+Oxaliplatin+Capecitabine)

Recruiting
  • Tislelizumab
  • +7 more
  • Beijing, China
    Lin Yang
Jul 21, 2023

Acoustic Stimulation, Parkinson Disease, Electroencephalography Trial (Upper-limb training involving RAS, Upper-limb training

Not yet recruiting
  • Acoustic Stimulation
  • +2 more
  • Upper-limb training involving RAS
  • Upper-limb training without the aid of RAS
  • (no location specified)
Mar 13, 2023

Recurrent Aphthous Stomatitis Trial (a-Mangostin Hydrogel Film With Chitosan Alginate Base, Placebo)

Not yet recruiting
  • Recurrent Aphthous Stomatitis
  • α-Mangostin Hydrogel Film With Chitosan Alginate Base
  • Placebo
  • (no location specified)
Sep 14, 2023

Primary Immune Thrombocytopenia (ITP) Trial in Tianjin (TPO-RAs, TPO-RAs combining anti-CD 20 mAb)

Not yet recruiting
  • Primary Immune Thrombocytopenia (ITP)
  • TPO-RAs
  • TPO-RAs combining anti-CD 20 monoclonal antibody
  • Tianjin, China
    Institute of Hematology and Blood Diseases Hospital, Chinese Aca
Feb 7, 2023

Stroke, Old Age Trial in Boston (Subject-specific optimized RAS, Active walking)

Recruiting
  • Stroke
  • Old Age
  • Subject-specific optimized RAS
  • Active walking
  • Boston, Massachusetts
    Boston University Neuromotor Recovery Laboratory
Oct 13, 2023

Advanced or Metastatic Solid Tumors Trial (Naporafinib, Trametinib)

Not yet recruiting
  • Advanced or Metastatic Solid Tumors
  • (no location specified)
Jun 21, 2023

Colorectal Cancer Trial in Changsha (fruquintinib and FOLFIRI)

Not yet recruiting
  • Colorectal Cancer
  • fruquintinib and FOLFIRI
  • Changsha, Hunan, China
    Hunan Cancer hospital
Apr 24, 2023

Parkinson Disease Trial in Boston (Subject-specific optimized RAS, Active Walking)

Recruiting
  • Parkinson Disease
  • Subject-specific optimized RAS
  • Active Walking
  • Boston, Massachusetts
    Boston University Neuromotor Recovery Laboratory
Feb 20, 2023

Colorectal Cancer, Liver Metastases Trial in Shanghai (mFOLFOX6 + Cetuximab, mFOLFOX 6)

Not yet recruiting
  • Colorectal Cancer
  • Liver Metastases
  • mFOLFOX6 + Cetuximab
  • mFOLFOX 6
  • Shanghai, China
    Zhongshan hosptial, Fudan University
Jul 14, 2023

Colorectal Cancer Trial (Tislelizumab, Irinotecan Hydrochloride, cetuximab)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Mar 23, 2023

Colo-rectal Cancer Trial (biological, drug, procedure)

Not yet recruiting
  • Colo-rectal Cancer
  • Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine
  • +8 more
  • (no location specified)
Aug 28, 2023

Metastatic Colorectal Cancer Trial (Cetuximab + Envafolimab + mFOLFOXIRI, Cetuximab + mFOLFOX6/FOLFIRI)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Cetuximab + Envafolimab + mFOLFOXIRI
  • Cetuximab + mFOLFOX6/FOLFIRI
  • (no location specified)
Jul 24, 2023

Vectibix With Chemotherapy for Metastatic Colorectal Cancer

Completed
Has Results
  • Wild-type RAS Metastatic Colorectal Cancer
  • Panitumumab + Chemotherapy
  • (no location specified)
Nov 4, 2022

Schizophrenia, Psychosis, Parkinsonism Trial in Kowloon (Rhythmic auditory stimulation (RAS) for schizophrenia patients, No RAS

Recruiting
  • Schizophrenia
  • +3 more
  • Rhythmic auditory stimulation (RAS) for schizophrenia patients
  • +3 more
  • Kowloon, Hong Kong
    Hong Kong Polytechnic University
May 20, 2022

Metastatic Colorectal Cancer Trial in Shanghai (Fruquintinib, FOLFIRI, mFOLFOX6)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Shanghai, Shanghai, China
    Department of Colorectal Surgery Fudan University Shanghai Caner
Nov 23, 2022

Rectal Cancer Trial (PD-1, SCRT, Bevacizumab)

Not yet recruiting
  • Rectal Cancer
  • (no location specified)
Dec 6, 2022

Unresectable Colon Cancer Peritoneal Metastases, PMMR/Ras/BRAF Wild-type Trial in Huzhou (Serplulimab Combined With FOLFIRI and

Recruiting
  • Unresectable Colon Cancer Peritoneal Metastases
  • PMMR/Ras/BRAF Wild-type
  • Serplulimab Combined With FOLFIRI and Bevacizumab
  • Huzhou, Zhejiang, China
    Changxing County People's Hospital
Feb 14, 2023

Advanced Solid Tumors Trial in Cincinnati, Houston, Salt Lake City (YL-17231)

Not yet recruiting
  • Advanced Solid Tumors
  • Cincinnati, Ohio
  • +2 more
Oct 22, 2023

New Prognostic Score for Adult RAS Wild-type mCRC Treated With

Active, not recruiting
  • Metastatic Colorectal Cancer
  • RAS Wild-type
  • Freiburg, Baden-Württemberg, Germany
    Praxis für interdisziplinäre Onkologie & Hämatologie
Jul 29, 2022

Acoustic Stimulation, Parkinson Disease, Movement, Abnormal Trial (Upper-limb movement training with the aid of RAS, Upper-limb

Not yet recruiting
  • Acoustic Stimulation
  • +4 more
  • Upper-limb movement training with the aid of RAS
  • Upper-limb movement training without the aid of RAS
  • (no location specified)
Dec 12, 2022

Colorectal Cancer Metastatic Trial in Guangzhou (Dexamethasone, Anisodamine, Oxaliplatin)

Recruiting
  • Colorectal Cancer Metastatic
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Feb 3, 2023

Metastatic Colorectal Cancer, RAS Wild Type Trial in Napoli (Avelumab, Cetuximab)

Completed
  • Metastatic Colorectal Cancer
  • RAS Wild Type
  • Napoli, Italy
    Università della Campania Luigi Vanvitelli
May 4, 2022

Colorectal Cancer Trial in Hangzhou (Ametumumab, Anti-PD-1 mAb, Cetuximab)

Not yet recruiting
  • Colorectal Cancer
  • Hangzhou, Zhejiang, China
    Sir Run Run Shaw Hospital, Zhejiang University School of Medicin
Jan 30, 2023